Memphis Internal Medicine is a clinical research site located in Memphis, Tennessee, United States 38119.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Memphis Internal Medicine has participated in 3 clinical trials.
Therapeutic areas: Diabetes Mellitus, Type 2, Diabetic Neuropathy, Painful, Acute Coronary Syndrome.
Sponsors: Mannkind Corporation, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Cogentus Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Memphis
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Memphis Internal Medicine has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memphis Internal Medicine has 3 clinical trials on record. Their work covers Diabetes Mellitus, Type 2, Diabetic Neuropathy, Painful, Acute Coronary Syndrome.
Memphis Internal Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.